Inventor · disambiguated record
Tobias Ginman
Also filed as: GINMAN TOBIAS
9 granted patents·2 pending applications·11 citations·filing 2017–2023
80Inventor score
Top patents by PatentIndex Score
11 records- 0193US11633403B26-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2021·Granted Apr 25, 2023·3 cites·20 claims
- 0287US11208423B2Pyridinamine-pyridone and pyrimidinamine- pyridone compoundsSPRINT BIOSCIENCE AB·Filed 2018·Granted Dec 28, 2021·3 cites·17 claims
- 0384US11179399B26-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2017·Granted Nov 23, 2021·3 cites·36 claims
- 0477US11219618B2Pyridylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2018·Granted Jan 11, 2022·2 cites·17 claims
- 0573US2024050439A16-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetesSpring Bioscience AB·Filed 2023·Application pending·0 cites
- 0668US11780858B2Pyridinamine-pyridone and pyrimidinamine-pyridone compoundsSPRINT BIOSCIENCE AB·Filed 2021·Granted Oct 10, 2023·0 cites·17 claims
- 0765US11963963B26-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 0862US2022218688A1Pyridylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2021·Application pending·0 cites
- 0959US11077113B26-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2017·Granted Aug 3, 2021·0 cites·23 claims
- 1043US11584763B2Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Feb 21, 2023·0 cites·16 claims
- 1140US11919902B2Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Mar 5, 2024·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →